155 related articles for article (PubMed ID: 31194241)
1. Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers.
Dreijerink KMA; Rijken JA; Compaijen CJ; Timmers HJLM; van der Horst-Schrivers ANA; van Leeuwaarde RS; van Dam PS; Leemans CR; van Dam EWCM; Dickhoff C; Dommering CJ; de Graaf P; Zwezerijnen GJC; van der Valk P; Menke-Van der Houven van Oordt CW; Hensen EF; Corssmit EPM; Eekhoff EMW
J Clin Endocrinol Metab; 2019 Nov; 104(11):5421-5426. PubMed ID: 31194241
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
3. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
4. Screening of a Large Cohort of Asymptomatic SDHx Mutation Carriers in Routine Practice.
Saie C; Buffet A; Abeillon J; Drui D; Leboulleux S; Bertherat J; Zenaty D; Storey C; Borson-Chazot F; Burnichon N; Vincent M; Favier J; Baudin E; Giraud S; Gimenez-Roqueplo AP; Amar L; Lussey-Lepoutre C
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1301-e1315. PubMed ID: 33247927
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
6. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
[TBL] [Abstract][Full Text] [Related]
7. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
[TBL] [Abstract][Full Text] [Related]
8. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K
BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685
[TBL] [Abstract][Full Text] [Related]
9. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
10. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.
van der Tuin K; Mensenkamp AR; Tops CMJ; Corssmit EPM; Dinjens WN; van de Horst-Schrivers ANA; Jansen JC; de Jong MM; Kunst HPM; Kusters B; Leter EM; Morreau H; van Nesselrooij BMP; Oldenburg RA; Spruijt L; Hes FJ; Timmers HJLM
J Clin Endocrinol Metab; 2018 Feb; 103(2):438-445. PubMed ID: 29177515
[TBL] [Abstract][Full Text] [Related]
11. Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.
Bayley JP; Oldenburg RA; Nuk J; Hoekstra AS; van der Meer CA; Korpershoek E; McGillivray B; Corssmit EP; Dinjens WN; de Krijger RR; Devilee P; Jansen JC; Hes FJ
BMC Med Genet; 2014 Oct; 15():111. PubMed ID: 25300370
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
[TBL] [Abstract][Full Text] [Related]
13. No difference in phenotype of the main Dutch SDHD founder mutations.
van Hulsteijn LT; den Dulk AC; Hes FJ; Bayley JP; Jansen JC; Corssmit EP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):824-31. PubMed ID: 23586964
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.
Timmers HJ; Gimenez-Roqueplo AP; Mannelli M; Pacak K
Endocr Relat Cancer; 2009 Jun; 16(2):391-400. PubMed ID: 19190077
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the SDHB and SDHD genes.
Pawlu C; Bausch B; Neumann HP
Fam Cancer; 2005; 4(1):49-54. PubMed ID: 15883710
[TBL] [Abstract][Full Text] [Related]
16. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.
Timmers HJ; Kozupa A; Eisenhofer G; Raygada M; Adams KT; Solis D; Lenders JW; Pacak K
J Clin Endocrinol Metab; 2007 Mar; 92(3):779-86. PubMed ID: 17200167
[TBL] [Abstract][Full Text] [Related]
18. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
19. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]